Good evening :)
Place Order
Add to Watchlist

Lupin Ltd

LUPIN

Lupin Ltd

LUPIN
Health CarePharmaceuticals
MidcapWith a market cap of ₹57,391 cr, stock is ranked 123
Moderate RiskStock is 2.47x as volatile as Nifty
1,258.200.19% (-2.35)
1,258.200.19% (-2.35)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
MidcapWith a market cap of ₹57,391 cr, stock is ranked 123
Moderate RiskStock is 2.47x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹57,391 cr, stock is ranked 123
Moderate RiskStock is 2.47x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
43.114.580.32%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.585.120.70%

Forecast & Ratings

Detailed Forecast 
31%
Analysts have suggested that investors can buy this stock

from 36 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.

Investor Presentation

View older 

Aug 4, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 1.03%, vs industry avg of 8.45%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 7.86% to 5.26%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 11.35%, vs industry avg of 9.82%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue13,009.7614,445.6317,482.1415,950.4215,095.7815,992.5615,300.5816,615.9316,792.5718,723.38
Raw Materialssubtract4,302.734,778.495,339.315,111.625,150.545,422.055,847.106,679.566,626.0315,720.43
Power & Fuel Costsubtract362.81381.27377.86433.88442.28443.17414.48443.96479.68
Employee Costsubtract1,747.342,141.622,849.522,864.712,770.172,986.842,825.902,989.303,087.15
Selling & Administrative Expensessubtract1,803.612,369.262,377.172,386.872,513.072,541.162,230.632,490.562,755.54
Operating & Other expensessubtract933.93899.551,930.383,316.311,567.762,378.811,277.973,583.281,972.69
Depreciation/Amortizationsubtract434.70487.13912.231,085.87846.05970.22887.411,658.71880.69966.90
Interest & Other Itemssubtract9.8159.47152.53204.35302.49362.98140.64142.77274.30342.95
Taxes & Other Itemssubtract1,011.591,068.10985.68295.55896.871,156.72459.92155.83286.41361.74
EPS53.5350.2356.705.5613.41-5.9526.83-33.659.4629.26
DPS7.507.507.505.005.006.006.504.004.004.00
Payout ratio0.140.150.130.900.370.240.420.14

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 19PDF
Feb 4PDF
Jan 12PDF
Oct 28PDF
FY 2023

Annual report

PDF

Investor Presentation

May 10PDF
Feb 10PDF
Jan 10PDF
+2 more
FY 2024

Annual Report Pending

Investor Presentation

Aug 4PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Lupin Ltd133.444.580.32%
Sun Pharmaceutical Industries Ltd34.864.980.93%
Cipla Ltd35.054.140.70%
Dr Reddy's Laboratories Ltd21.264.120.70%

Price Comparison

Compare LUPIN with any stock or ETF
Compare LUPIN with any stock or ETF
LUPIN
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 1.06%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding47.06%16.71%12.71%14.99%8.53%

Dec 2022

Mar 2023

Jun 2023

Sep 2023

Shareholding History

JunSepDec '22MarJunSep14.27%13.81%13.98%13.32%13.94%14.99%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Lupin Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
HDFC Balanced Advantage Fund - Growth - Direct Plan

Growth
1.1504%1.03%0.09%19/233 (0)
ICICI Prudential Bluechip Fund - Growth - Direct Plan

Growth
0.9930%1.38%-0.12%19/87 (-5)
ICICI PRUDENTIAL VALUE DISCOVERY FUND - DIRECT PLAN - GROWTH

Growth
0.8751%1.55%0.20%53/96 (0)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Trend In Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

LUPIN has shown inconsistent dividend trend over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.31%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.08 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 14, 2023

Final
Final | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Jul 14, 2023

Cash Dividend

Ex DateEx DateJul 14, 2022

Final
Final | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Jul 14, 2022

Cash Dividend

Ex DateEx DateJul 27, 2021

Final
Final | Div/Share: ₹6.50

Dividend/Share

6.50

Ex DateEx Date

Jul 27, 2021

Cash Dividend

Ex DateEx DateAug 3, 2020

Final
Final | Div/Share: ₹6.00

Dividend/Share

6.00

Ex DateEx Date

Aug 3, 2020

Cash Dividend

Ex DateEx DateJul 29, 2019

Final
Final | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Jul 29, 2019